These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26231042)

  • 1. Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
    Li J; Lam M;
    Elife; 2015 Jul; 4():e06434. PubMed ID: 26231042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
    Yan X; Tang B; Chen B; Shan Y; Yang H;
    Elife; 2019 Mar; 8():. PubMed ID: 30860027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Registered report: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.
    Khan I; Kerwin J; Owen K; Griner E; ;
    Elife; 2015 Sep; 4():. PubMed ID: 26335297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Registered report: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.
    Lesnik J; Antes T; Kim J; Griner E; Pedro L; ;
    Elife; 2016 Jan; 5():e07383. PubMed ID: 26826285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Registered report: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis.
    Fiering S; Ang LH; Lacoste J; Smith TD; Griner E;
    Elife; 2015 Jul; 4():e04796. PubMed ID: 26179155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.
    Yu G; Yao W; Xiao W; Li H; Xu H; Lang B
    J Exp Clin Cancer Res; 2014 Dec; 33(1):779. PubMed ID: 25551284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
    Liu C; Kelnar K; Liu B; Chen X; Calhoun-Davis T; Li H; Patrawala L; Yan H; Jeter C; Honorio S; Wiggins JF; Bader AG; Fagin R; Brown D; Tang DG
    Nat Med; 2011 Feb; 17(2):211-5. PubMed ID: 21240262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Registered report: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment.
    Evans J; Essex A; Xin H; Amitai N; Brinton L; Griner E; ;
    Elife; 2015 Aug; 4():. PubMed ID: 26287525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Registered report: Systematic identification of genomic markers of drug sensitivity in cancer cells.
    Vanden Heuvel JP; Bullenkamp J;
    Elife; 2016 Jun; 5():. PubMed ID: 27336789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Registered report: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs.
    Phelps M; Coss C; Wang H; Cook M; ;
    Elife; 2016 Mar; 5():. PubMed ID: 26943900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
    Bhargava A; Pelech S; Woodard B; Kerwin J; Maherali N; ;
    Elife; 2016 Feb; 5():. PubMed ID: 26882073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Registered report: A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.
    Haven B; Heilig E; Donham C; Settles M; Vasilevsky N; Owen K; ;
    Elife; 2016 Feb; 5():. PubMed ID: 26905833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Registered report: Diverse somatic mutation patterns and pathway alterations in human cancers.
    Sharma V; Young L; Allison AB; Owen K; ;
    Elife; 2016 Feb; 5():. PubMed ID: 26894955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Registered report: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia.
    Fung JJ; Kosaka A; Shan X; Danet-Desnoyers G; Gormally M; Owen K; ;
    Elife; 2015 Sep; 4():. PubMed ID: 26327698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Registered report: Interactions between cancer stem cells and their niche govern metastatic colonization.
    Incardona F; Doroudchi MM; Ismail N; Carreno A; Griner E; Anna Lim M;
    Elife; 2015 Jun; 4():e06938. PubMed ID: 26086719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Registered report: Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF.
    Bhargava A; Anant M; Mack H; ;
    Elife; 2016 Feb; 5():. PubMed ID: 26885666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Registered report: IDH mutation impairs histone demethylation and results in a block to cell differentiation.
    Richarson AD; Scott DA; Zagnitko O; Aza-Blanc P; Chang CC; Russler-Germain DA;
    Elife; 2016 Mar; 5():e10860. PubMed ID: 26971564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Registered Report: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.
    Sharma V; Young L; Cavadas M; Owen K;
    Elife; 2016 Mar; 5():. PubMed ID: 26999821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.
    Kandela I; Chou J; Chow K;
    Elife; 2015 May; 4():. PubMed ID: 27879198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer.
    Chen WY; Liu SY; Chang YS; Yin JJ; Yeh HL; Mouhieddine TH; Hadadeh O; Abou-Kheir W; Liu YN
    Oncotarget; 2015 Jan; 6(1):441-57. PubMed ID: 25436980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.